Intensive treatment for the progression of joint damage in rheumatoid arthritis patients with low disease activity or remission

被引：0

作者：

Mochizuki, Takeshi ^{[1
,4
]}

Koenuma, Naoko ^{[2
]}

Yano, Koichiro ^{[2
]}

Ikari, Katsunori ^{[2
,3
]}

Hiroshima, Ryo ^{[1
]}

Okazaki, Ken ^{[2
]}

机构：

[1] Kamagaya Gen Hosp, Dept Orthopaed Surg, Chiba, Japan

[2] Tokyo Womens Med Univ, Dept Orthopaed Surg, Tokyo, Japan

[3] Tokyo Womens Med Univ, Div Multidisciplinary Management Rheumat Dis, Tokyo, Japan

[4] Kamagaya Gen Hosp, Dept Orthopaed Surg, 929-6 Hatsutomi, Kamagaya, Chiba 2730121, Japan

来源：

MODERN RHEUMATOLOGY | 2024年 / 34卷 / 02期

关键词：

Intensive treatment; joint damage; low disease activity; remission; rheumatoid arthritis; AMERICAN-COLLEGE; METHOTREXATE; THERAPY; DRUG;

D O I：

10.1093/mr/road041

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives To investigate the effects of intensive treatment on joint damage in patients with rheumatoid arthritis (RA) showing progression of joint damage and low disease activity or remission. Methods Eighty-nine patients who had change in the van der Heijde modified total Sharp score (TSS) of >0.5 points at baseline when compared with the score 1 year ago were enrolled and categorized into two groups to receive intensive (intensive group) or current (current group) treatment. The intensive and current groups were compared for change (Delta) from baseline to 1 year of erosion score, joint space narrowing score, and TSS. Results The Delta TSS values at 1 year in the intensive and current groups were 0.67 +/- 1.09 and 1.79 +/- 1.70, respectively (P < 0.001). In the intensive and current groups, the Delta TSS <= 0.5 at 1 year were 66.7% and 32.4%, respectively (P = 0.010). Conclusions The intensive treatment was more effective at suppressing joint damage than the current treatment. The progression of joint damage is an important target to consider for intensive treatment.

引用

页码：329 / 333

页数：5

共 20 条

[1] Rheumatoid Arthritis Joint Progression in Sustained Remission Is Determined by Disease Activity Levels Preceding the Period of Radiographic Assessment [J].

Aletaha, D. ;

Funovits, J. ;

Breedveld, F. C. ;

Sharp, J. ;

Segurado, O. ;

Smolen, J. S. .

ARTHRITIS AND RHEUMATISM, 2009, 60 (05) :1242-1249

[2] An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis [J].

Brown, A. K. ;

Conaghan, P. G. ;

Karim, Z. ;

Quinn, M. A. ;

Ikeda, K. ;

Peterfy, C. G. ;

Hensor, E. ;

Wakefield, R. J. ;

O'Connor, P. J. ;

Emery, P. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (10) :2958-2967

[3]

Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI [10.1136/ard.2011.149765, 10.1002/art.30129]

[4] 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis [J].

Fraenkel, Liana ;

Bathon, Joan M. ;

England, Bryant R. ;

St Clair, E. William ;

Arayssi, Thurayya ;

Carandang, Kristine ;

Deane, Kevin D. ;

Genovese, Mark ;

Huston, Kent Kwas ;

Kerr, Gail ;

Kremer, Joel ;

Nakamura, Mary C. ;

Russell, Linda A. ;

Singh, Jasvinder A. ;

Smith, Benjamin J. ;

Sparks, Jeffrey A. ;

Venkatachalam, Shilpa ;

Weinblatt, Michael E. ;

Al-Gibbawi, Mounir ;

Baker, Joshua F. ;

Barbour, Kamil E. ;

Barton, Jennifer L. ;

Cappelli, Laura ;

Chamseddine, Fatimah ;

George, Michael ;

Johnson, Sindhu R. ;

Kahale, Lara ;

Karam, Basil S. ;

Khamis, Assem M. ;

Navarro-Millan, Iris ;

Mirza, Reza ;

Schwab, Pascale ;

Singh, Namrata ;

Turgunbaev, Marat ;

Turner, Amy S. ;

Yaacoub, Sally ;

Akl, Elie A. .

ARTHRITIS & RHEUMATOLOGY, 2021, 73 (07) :1108-1123

[5] Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug A Randomized Clinical Trial [J].

Gottenberg, Jacques-Eric ;

Brocq, Olivier ;

Perdriger, Aleth ;

Lassoued, Slim ;

Berthelot, Jean-Marie ;

Wendling, Daniel ;

Euller-Ziegler, Liana ;

Soubrier, Martin ;

Richez, Christophe ;

Fautrel, Bruno ;

Constantin, Arnaud L. ;

Mariette, Xavier ;

Morel, Jacques ;

Gilson, Melanie ;

Cormier, Gregoire ;

Salmon, Jean Hugues ;

Rist, Stephanie ;

Liote, Frederic ;

Marotte, Hubert ;

Bonnet, Christine ;

Marcelli, Christian ;

Sellam, Jeremie ;

Meyer, Olivier ;

Solau-Gervais, Elisabeth ;

Guis, Sandrine ;

Ziza, Jean-Marc ;

Zarnitsky, Charles ;

Chary-Valckenaere, Isabelle ;

Vittecoq, Olivier ;

Saraux, Alain ;

Pers, Yves-Marie ;

Gayraud, Martine ;

Bolla, Gilles ;

Claudepierre, Pascal ;

Ardizzone, Marc ;

Dernis, Emmanuelle ;

Breban, Maxime A. ;

Fain, Olivier ;

Balblanc, Jean-Charles ;

Aberkane, Ouafaa ;

Vazel, Marion ;

Back, Christelle ;

Candon, Sophie ;

Chatenoud, Lucienne ;

Perrodeau, Elodie ;

Sibilia, Jean ;

Ravaud, Philippe .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (11) :1172-1180

[6] Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice [J].

Katayama, Kou ;

Okubo, Takanobu ;

Sato, Toshikazu ;

Ito, Hiroshi ;

Fukai, Richio ;

Baba, Hisashi .

MODERN RHEUMATOLOGY, 2015, 25 (01) :50-55

[7] Increased radiographic damage scores at the onset of seropositive rheumatoid arthritis in older patients are associated with osteoarthritis of the hands, but not with more rapid progression of damage [J].

Khanna, D ;

Ranganath, VK ;

FitzGerald, J ;

Park, GS ;

Altman, RD ;

Elashoff, D ;

Gold, RH ;

Sharp, JT ;

Furst, DE ;

Paulus, HE .

ARTHRITIS AND RHEUMATISM, 2005, 52 (08) :2284-2292

[8] Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission [J].

Kuriya, B. ;

Arkema, E. V. ;

Bykerk, V. P. ;

Keystone, E. C. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) :1298-1304

[9] Continuously elevated serum matrix metalloproteinase-3 for 3 ∼ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study [J].

Ma, Jian-Da ;

Wei, Xiu-Ning ;

Zheng, Dong-Hui ;

Mo, Ying-Qian ;

Chen, Le-Feng ;

Zhang, Xiang ;

Li, Jing-Hua ;

Dai, Lie .

ARTHRITIS RESEARCH & THERAPY, 2015, 17

[10] The usefulness of a new triple combination treatment utilizing methotrexate, salazosulfapyridine, and bucillamine in rheumatoid arthritis [J].

Matsuno, Hiroaki ;

Okada, Masato ;

Sakai, Yoshitada ;

Abe, Chiyuki ;

Katayama, Kou ;

Sagawa, Akira ;

Yamasaki, Kuniomi ;

Kondo, Masakazu ;

Funahashi, Keiko ;

Matsubara, Tsukasa .

MODERN RHEUMATOLOGY, 2016, 26 (01) :51-56

← 1 2 →